Advertisement

Topics

Medivizor Company Profile

01:35 EST 14th December 2018 | BioPortfolio

Medivizor offers a patent-pending, personalized health information platform for individuals with serious or chronic illnesses. Users of Medivizor are benefiting from custom content, cutting-edge research, clear and authoritative descriptions of treatment options, individual-matched clinical trials, social engagement, and much more. Professor Steven Kaplan, M.D., Chief Medical Officer, and Chief of the Institute of Bladder and Prostate Health at Weill Cornell Medical College and co-founder of MediData Solutions (NASDAQ: MDSL), Dr. Oren Fuerst, Executive Chairman, a medtech entrepreneur and investor and Tal Givoly, CEO, former Chief Scientist of Amdocs (NYSE: DOX) founded Medivizor.


News Articles [0 Results]

None

Drugs and Medications [0 Results]

None

PubMed Articles [0 Results]

None

Clinical Trials [0 Results]

None

Companies [1 Associated Companies listed on BioPortfolio]

Medivizor

Medivizor offers a patent-pending, personalized health information platform for individuals with serious or chronic illnesses. Users of Medivizor are benefiting from custom...

More Information about "Medivizor" on BioPortfolio

We have published hundreds of Medivizor news stories on BioPortfolio along with dozens of Medivizor Clinical Trials and PubMed Articles about Medivizor for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Medivizor Companies in our database. You can also find out about relevant Medivizor Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Nutrition
Within medicine, nutrition (the study of food and the effect of its components on the body) has many different roles. Appropriate nutrition can help prevent certain diseases, or treat others. In critically ill patients, artificial feeding by tubes need t...


Corporate Database Quicklinks



Searches Linking to this Company Record